No Signal — Quality Gated
The directional consensus did not pass the post-analysis signal-quality review.
Weak multi-run long spread 0.3 had no baseline regime alignment (neutral).
Weak multi-run long spread 0.3 had no baseline regime alignment (neutral).
Evidence spread reviewed from 0.3 to 0.3.
Both models agree that TSLA is currently testing confluent support near $351.50, where a successful hold above rising SMA20s ($330.37) and a bullish moving-average stack could trigger a mean-reversion bounce. This long setup is supported by a potential August deliveries beat and structural catalysts like the Nevada regulatory approval for 5,000 robotaxis, which could drive a retest of the $366-$369 resistance cluster. One model specifically highlights a high-conviction empirical cohort with an 18.3pp win-rate spread, suggesting a swing recovery toward $380 over a 1-3 week horizon if momentum sustains.
All three models flag a technical rejection at the $366-$369 resistance zone, exacerbated by a 2.98M-vehicle China recall and a bearish 30-minute MACD zero-cross. Momentum is deteriorating as the RSI falls and the stock leads broader tech weakness (QQQ -1.26%), with two models warning that a break below the $351 support level opens a path to the $330-$337 SMA20 shelf. If selling accelerates, the lack of high-volume nodes suggests a deeper correction toward the volume profile Point of Control (POC) at $321.95 or even the $310 psychological level.
TSLA is pulling back into confluent 4h/1day support at ~ $351.5 after a -2.51% session, sitting just above rising SMA20s with a bullish 4h moving-average stack and improving 1day MACD histogram, offering an actionable long from support rather than into resistance. The path higher is relatively unobstructed through the low-volume node at $360 toward the SMA 50/resistance cluster at $366-369, and the empirical long cohort (62% shrunk win rate, +18.3pp spread, 3W/0L same-symbol history that survived similar drawdowns) reinforces the mean-reversion bounce case. A hold of support plus positive robotaxi/deliveries newsflow supports a swing recovery over 1-3 weeks.
TSLA closed down -2.51% pressed directly against 4h/1day support at $351.42- $351.61 with a bearish 30-min MACD zero-cross and RSI collapsing -20.74, signaling near-term supply. A confirmed break below $351.40 opens air to the SMA 20/value-area shelf near $335-337 since the next real high-volume node sits far below at POC $321.95, and QQQ (-1.26%) plus a completed 2.98M-vehicle China recall provide bearish read-through. Selling into a support failure on a high-beta name (1.83) during a rotation-out-of-tech session sets up a swing continuation lower.
TSLA is rejecting from the $366-369 resistance zone (4h resistance at $369.02, 1d SMA50 at $364.95) with a fresh negative catalyst in the form of a China recall covering 2.98M vehicles, while the 30m timeframe shows a bearish MACD zero-cross and falling histogram confirming deteriorating momentum. The stock is leading tech weakness (QQQ -1.26%) lower, and with volume depressed at the 14th percentile, the path of least resistance is a breakdown through the $351 support toward the $330-312 zone where the 1d SMA20 and volume POC sit.
TSLA is pulling back to test the $351 support zone after rallying from $308 in late July, creating a clean support-retest entry for a swing long. The Nevada robotaxi regulatory approval (Aug 21) provides a structural catalyst for autonomous-vehicle re-rating, while the unverified August deliveries beat claim adds potential upside catalyst flow. With the 1-day RSI still constructive at 53.5 and rising, and price holding above the rising SMA20 ( $330) , the path of least resistance favors a reclaim toward the $369 resistance and potentially higher over the next 1-3 weeks.
TSLA presents a compelling long setup driven by a confluence of technical reclaim and a potential near-term catalyst. The stock has recently reclaimed its 4h SMA50 ($332.06) and is trading above its 1-day SMA20 ($330.37), signaling a shift in momentum. The reported August deliveries beat, though unverified, has already sparked pre-market interest, suggesting a potential upside repricing if confirmed. Additionally, the Nevada regulatory approval for up to 5,000 commercial robotaxis provides a structural catalyst for TSLA’s long-term growth narrative, which could attract dip-buying interest. With RSI on the 4h timeframe at 59.47 and rising off a recent pullback, the stock is poised for a retest of resistance at $369.02, with a potential path to $380 if momentum sustains.
TSLA is positioned for a short swing trade due to its technical rejection at a critical resistance zone and weakening momentum, despite recent unconfirmed claims of an August deliveries beat. The stock is currently trading at $353.76, just below the 4h resistance level of $369.02 and the 1day resistance of $366.96, both of which have acted as strong barriers in recent sessions. The RSI on the 4h timeframe has turned lower (59.47, falling over the last 3 bars), and the MACD histogram is declining, signaling a loss of upward momentum. This technical weakness, combined with the lack of confirmed bullish catalysts (e.g., the deliveries beat remains unverified), suggests a high probability of a pullback toward the nearest support levels. The first target is $321.95 (volume profile POC), with a potential extension to $310.00 if momentum accelerates.